Yesterday
Abbvie claims CMS’ selection of Botox violates the IRA BioWorld16:57 12-Feb-26
AbbVie mounts fresh IRA legal challenge over Botox's inclusion in latest drug pricing… FiercePharma14:14 12-Feb-26
Botox Maker Calls in Checkmate O'Dwyer's PR Daily13:13 12-Feb-26
1 Reason I'm Never Selling AbbVie Stock The Motley Fool05:29 12-Feb-26
In the last 7 days
AbbVie Sues Medicaid, HHS Over Botox Fair Price Controls Law36022:41 11-Feb-26
AbbVie Sues HHS Over Selection of Botox for Medicare Price Cuts Bloomberg Law18:03 11-Feb-26
J&J’s Tremfya roars into 2026 with massive TV ad spend, trailed by AbbVie’s Rinvoq and Skyrizi FiercePharma12:37 11-Feb-26
AbbVie’s $100bn deal aligns drug pricing with domestic manufacturing goals Pharmaceutical Technology11:09 10-Feb-26
Here's Why AbbVie (ABBV) is a Strong Value Stock Zacks10:50 10-Feb-26
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know Zacks10:09 10-Feb-26
Here's What Will Drive AbbVie's Top-line Growth in 2026 Zacks09:38 10-Feb-26
AbbVie, Astra Lose Appeal Over Louisiana Contract Pharmacy Law Bloomberg Law14:26 9-Feb-26
In the last month
S&P 500 Analyst Moves: ABBV Nasdaq13:12 5-Feb-26
AbbVie’s Real-World RINVOQ Data in Japan: What It Means for Ankylosing Spondylitis Investors TipRanks11:32 5-Feb-26
AbbVie Shares Fall as Wall Street Focuses on Filler Weakness The Business of Fashion06:07 5-Feb-26
AbbVie Earnings: Skyrizi Holds Steady Share Despite Competition MorningStar.com04:04 5-Feb-26
AbbVie, hitting record sales on Skyrizi gains, holds its own in growing IBD arena despite J&J… FiercePharma15:07 4-Feb-26
AbbVie Beats on Q4 Earnings, Stock Down Despite Upbeat '26 View Zacks13:38 4-Feb-26
AbbVie's Inflammation Drug Humira Slows, But Skyrizi, Rinvoq Drive Revenue Growth Benzinga12:42 4-Feb-26
AbbVie (ABBV) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates Zacks11:35 4-Feb-26
Q4 Earnings Summary: Eli Lilly and AbbVie Beat, Uber Mixed Investing.com UK11:25 4-Feb-26
Eli Lilly, Novo Nordisk, AbbVie: Pharma earnings roundup Yahoo! UK & Ireland11:16 4-Feb-26
AbbVie (ABBV) Tops Q4 Earnings and Revenue Estimates Zacks10:03 4-Feb-26
AbbVie Guides FY26 Adj. EPS Above Estimates; Q4 Results Top Estimates RTT News08:38 4-Feb-26
AbbVie’s (NYSE:ABBV) Q4 CY2025: Beats On Revenue Barchart08:33 4-Feb-26
AbbVie forecasts 2026 profit above estimates on strong sales of newer immunology drugs Yahoo! US08:10 4-Feb-26
AbbVie Reports Full-Year and Fourth-Quarter 2025 Financial Results PR Newswire (Press Release)07:48 4-Feb-26
2 Healthcare Dividend Stocks That are Just What the Doctor Ordered The Motley Fool17:54 3-Feb-26
A Preview Of AbbVie's Earnings Benzinga10:06 3-Feb-26
AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ®) in Adults and Adolescents With Vitiligo AbbVie (Press Release)08:01 3-Feb-26
AbbVie (ABBV) Q4 Earnings: What To Expect Barchart22:36 2-Feb-26
AbbVie’s Shift Beyond Humira With Skyrizi and Rinvoq Might Change The Case For Investing In AbbVie (ABBV) Simply Wall St14:08 2-Feb-26
AbbVie has ‘Love in Mind’ with new migraine educational campaign FiercePharma12:42 2-Feb-26
Buy AbbVie Stock Before Q4 Earnings? Here's What to Know Zacks11:40 2-Feb-26
Where Will AbbVie Be in 5 Years? The Motley Fool03:57 2-Feb-26
2 No-Brainer Dividend Stocks to Buy Hand Over Fist The Motley Fool06:35 1-Feb-26
Stay Ahead of the Game With AbbVie (ABBV) Q4 Earnings: Wall Street's Insights on Key Metrics Zacks10:29 30-Jan-26
AbbVie Stock: Analyst Estimates & Ratings Barchart09:03 30-Jan-26
AbbVie Launches Love in Mind™ to Spotlight the Emotional Impact of Migraine on Romantic Relationships AbbVie (Press Release)08:07 29-Jan-26
Tenpoint eyes presbyopia drug launch after FDA nod pharmaphorum06:21 29-Jan-26
AbbVie (ABBV) Dips More Than Broader Market: What You Should Know Zacks18:55 28-Jan-26
Why AbbVie Stock Trounced the Market in 2025 The Motley Fool17:08 28-Jan-26
AbbVie's Irish operations in firing line as Trump targets Botox prices Irish Examiner10:57 28-Jan-26
AbbVie, Slb, Amphenol, And More On CNBC's 'Final Trades' Benzinga08:21 28-Jan-26
CMS Names Pfizer, Eli Lilly, and AbbVie Drugs for Third Medicare Price Talks TipRanks02:36 28-Jan-26
AbbVie’s Elahere launches in Korea, marking 1st ADC for ovarian cancer Korea Biomedical Review23:52 27-Jan-26
Eli Lilly, Pfizer, AbbVie drugs targeted in third Medicare price talks Investing.com17:40 27-Jan-26
AbbVie and Novartis Announce Billion Dollar Licensing Deals for Oncology and Alzheimer’s Treatments JD Supra12:44 27-Jan-26
Is the Options Market Predicting a Spike in AbbVie Stock? Zacks09:45 27-Jan-26
The AbbVie Foundation Is Now Accepting Applications to Participate in the 2026 AbbVie… Business Wire (Press Release)09:36 27-Jan-26
AbbVie Advances Early-Stage ABBV-722 Tablet Study, Underscoring Pipeline Momentum TipRanks11:34 26-Jan-26
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It Zacks10:10 26-Jan-26
ABBV vs. MRK: An Oncology-Immunology Showdown for Investors Zacks13:06 22-Jan-26
Executives On The Move: Emmecell Gets A New CEO From AbbVie Scrip Pharma Intelligence13:02 22-Jan-26
Biocom Announces Powerhouse Keynote Panel Featuring Heads of Discovery and Research &… Business Wire (Press Release)09:02 21-Jan-26
The Smartest Dividend Stocks to Buy in 2026 With $1,000 Right Now -- Including Realty Income and AbbVie The Motley Fool00:59 19-Jan-26
The Bull Case For RemeGen (SEHK:9995) Could Change Following AbbVie’s RC148 Licensing Deal - Learn Why Simply Wall St19:43 16-Jan-26
After AbbVie and Genmab's ph. 3 survival miss for Epkinly in DLBCL, what's next? FiercePharma15:59 16-Jan-26
AbbVie Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE®… PR Newswire (Press Release)13:46 16-Jan-26
AbbVie’s Skyrizi takes full-year TV ad spending crown yet again, with J&J’s Tremfya in hot… FiercePharma11:23 16-Jan-26
Fierce Pharma Asia—AbbVie’s bispecific play, Illumina’s China import efforts and pharma execs’… FiercePharma09:10 16-Jan-26
JPM26: AbbVie highlights growth drivers as it moves away from Humira dependency Pharmaceutical Technology08:00 16-Jan-26
AbbVie (ABBV) Stock Dips While Market Gains: Key Facts Zacks18:48 15-Jan-26
J.P. Morgan: AbbVie Still Aims To Be A Major Obesity Player – With A Lift From Botox Scrip Pharma Intelligence13:50 15-Jan-26
AbbVie Still Aims To Be A Major Obesity Player – With A Lift From Botox Scrip Pharma Intelligence12:39 15-Jan-26
The Zacks Analyst Blog Highlights AbbVie, Intel, Boeing and Tandy Leather Factory Zacks11:51 15-Jan-26
AbbVie sets sights on immunology, neurology dominance Crain's Chicago Business09:09 15-Jan-26
Top Research Reports for AbbVie, Intel & Boeing Zacks17:59 14-Jan-26
AbbVie plans to build out its presence in obesity market Yahoo! US14:08 14-Jan-26
Ex-Dividend Reminder: AbbVie, Dime Community Bancshares and MidWestOne Financial Group Nasdaq10:35 14-Jan-26
Wall Street Bulls Look Optimistic About AbbVie (ABBV): Should You Buy? Zacks10:32 14-Jan-26
The AbbVie strategy, a company at an inflection point Labiotech09:53 14-Jan-26
AbbVie licenses novel bispecific antibody from RemeGen for $5bn European Pharmaceutical Review09:48 14-Jan-26
AbbVie reaches agreement for affordable prescription drugs with US government PMLiVE07:59 14-Jan-26
AbbVie To Buy Device Manufacturing Facility From West Pharmaceutical Services Pharmaceutical Online06:23 14-Jan-26
AbbVie pledges $100 billion U.S. investment to avoid tariffs Crain's Chicago Business17:35 13-Jan-26
And then there was one: Abbvie reaches Mfn pricing deal BioWorld16:56 13-Jan-26
Trump admin. strikes deal with AbbVie to cut costs of certain drugs ABC7 / WLS-TV14:17 13-Jan-26
Why AbbVie (ABBV) is a Top Value Stock for the Long-Term Zacks10:46 13-Jan-26
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know Zacks10:04 13-Jan-26
Will AbbVie's Oncology Segment Support Top-line Growth in Q4 Earnings? Zacks09:54 13-Jan-26
STAT Plus: Pharmalittle: We’re reading about a ‘breached’ FDA firewall, an AbbVie pricing deal… STAT09:33 13-Jan-26
AbbVie inks latest White House drug pricing deal, scoring tariff reprieve as it makes $100B US… FiercePharma09:26 13-Jan-26
AbbVie Gets Tariff Relief, Pledges $100 Billion, Lower Prices For Key Medicines Benzinga08:18 13-Jan-26
Breakfast News: Trading Revenue Lifts JPMorgan The Motley Fool08:00 13-Jan-26
AbbVie inks MFN drug pricing deal, pledges $100bn to US R&D Pharmaceutical Technology06:55 13-Jan-26
AbbVie turbocharges its US investment promise to $100bn pharmaphorum06:32 13-Jan-26

      
            
      
    view more headlines
   
      
      
      
12 Feb 16:57
   
AbbVie News

NewsNow aims to be the world's most accurate and comprehensive aggregator of AbbVie news, covering the latest share price, company announcements, vaccine trials, product news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.
AbbVie

Latest News

AbbVie News

Pharmaceuticals Top Stories

Business Top Stories
